浙江大学创新技术研究院有限公司

What 浙江大学创新技术研究院有限公司 does

浙江大学创新技术研究院有限公司 (Zhejiang University Innovation Technology Research Institute Co., Ltd., DBA 浙大创新院) is a Hangzhou-based private limited company established on 2012-09-29 with ¥500M registered capital, controlled by Zhejiang University Holdings Group on behalf of Zhejiang University, with co-investment from provincial and municipal SOEs (Zhejiang Provincial State-owned Capital Operations, Hangzhou Financial Investment Group, Zhejiang Transportation Investment) and listed companies (Zhejiang Huahai, NHU, Conba, Insigitek, Xizi United, Shenwu Environmental, Rongsheng Group, Changjiang Innovation, Jinshajiang United). The institute operates as Zhejiang University's official technology transfer and science investment platform, identifying, incubating, and investing in high-tech projects originating from ZJU labs and partner research institutions across life and health sciences, new materials, intelligent manufacturing, semiconductors, and artificial intelligence.

The platform encompasses two wholly-owned technology transfer subsidiaries (Zhejiang Qizhen Yushan Technology for food science; Zhejiang Qizhen Medical Health Technology for medical-engineering projects from ZJU-affiliated hospitals), the Qizhen Yuxiu Training Center (启真毓秀培训中心) sub-brand for innovation/entrepreneurship education, and the Qizhen Yuxiu Lecture Hall (启真毓秀大讲堂) seminar series. It manages or co-manages 14+ venture capital and private equity funds with total AUM exceeding ¥6B, including the ZJU Parent Fund (¥500M), Zhehua Zijing Parent Fund (¥3B), Suzhou Jinshajiang Phase II (¥1-1.5B), Haibang Biomedical Fund (¥300M), Hangzhou Silicon Valley 2.0 Fund, and multiple Hangzhou/Haining/Jiaxing vehicles. The portfolio comprises 30+ incubated/invested companies with notable holdings including Hangzhou Feibu Technology (autonomous driving AI, 2025 China Ports Association Science & Technology Progress Special Prize), Zhejiang Bangsheng Technology (unicorn, financial real-time risk control), Tongdun Technology (unicorn), Yingpai Pharma (HKEX 07630 in 2025), and others recognized as national specialized/innovative SMEs or Hangzhou/Zhejiang unicorns.

The institute earns revenue through three principal streams: (1) equity appreciation and exit proceeds (IPO/M&A) from portfolio investments; (2) management fees and carried interest from fund operations; and (3) training program tuition and government talent-development subsidies (e.g., Jiangmen entrepreneurship training at ¥12,000/list price with ¥10,000 government subsidy and ¥2,000 self-pay per participant). The 13-employee team operates asset-light, focusing on sourcing, diligence, and ecosystem curation rather than hands-on operational support. Headquarters are located in the Zheshang Fortune Center complex in Xihu District, Hangzhou, which the institute partly owns and manages, with the Investment Department in office 919 and core operations on the 10th floor.

Name

浙江大学创新技术研究院有限公司

Legal name

浙江大学创新技术研究院有限公司

Website

https://zjuiti.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

Hangzhou-based technology transfer and investment platform founded in 2012 by Zhejiang University with ¥500M registered capital, managing ¥6B+ across 14+ VC/PE funds and a portfolio of 30+ incubated companies spanning life sciences, AI, semiconductors, and new materials.

Ownership category

akta.pro rank

Product category

Technology Transfer & Venture Capital Management

SIC

Investment Advice (6282)

akta.pro primary industry

Technology Transfer & Innovation-Driven Research Universities (High Commercialization) (EDAHABAH)

akta.pro secondary industries

Technical Universities with Computing, Data & AI Focus (EDAHAEAK), Technical Universities with Strong Industry Partnerships (EDAHAEAG)

Keywords

• Technology transfer
• Venture capital
• Startup incubation
• Research commercialization
• Entrepreneurship training

Headquarters

HQ city

Hangzhou

HQ country

China

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Technology Transfer & Commercialization Services: The institute earns revenue by identifying, incubating, and investing in high-tech projects originating from Zhejiang University and partner research institutions. Returns are realized through equity appreciation, exit via IPO or M&A of portfolio companies, and management fees from associated funds.
2. Investment Management & Fund Administration: The company participates as LP/GP in multiple venture capital and private equity funds (e.g., 苏州金沙江二期基金, 浙大母基金, 海邦生物医药基金) and earns management fees and performance carried interest from fund operations.
3. Training & Education Programs: The 启真毓秀培训中心 organizes training programs, innovation competitions, and industry forums. Revenue is generated from program fees, sponsorship deals, and government subsidies for talent development initiatives.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Zhejiang University Innovation Technology Research Institute is a privately-held technology transfer and investment platform that identifies, incubates, and invests in high-tech projects originating from Zhejiang University and partner research institutions. The institute operates subsidiary technology transfer platforms in food science and medical health, manages multiple venture capital and parent funds exceeding 6 billion RMB in aggregate AUM, and runs the Qizhen Yuxiu Training Center for innovation and entrepreneurship education across focus areas of life and health, new materials, intelligent manufacturing, and semiconductors.

Product overview

浙江大学创新技术研究院有限公司 operates as a technology transfer and investment platform for Zhejiang University. The organization encompasses multiple subsidiary platforms including Zhejiang Qizhen Yushan Technology (food science technology transfer), Zhejiang Qizhen Medical Health Technology (medical health technology transfer), and Qizhen Yuxiu Training Center. The company manages various investment funds and has a portfolio of incubated/ invested companies spanning autonomous driving AI (Hangzhou Feibu Technology), financial big data risk control (Zhejiang Bangsheng Technology), cardiovascular diagnostics (Hangzhou Shengshi Technology), and medical devices (Puang Medical).

Differentiator

Problem solved

Functional benefit

Brands

• 启真毓秀培训中心: Training center established by the institute for innovation and entrepreneurship education, offering programs in technology policy, business incubation, tech finance, IP protection, and corporate management.
• 启真毓秀大讲堂

Products and services

• Qizhen Yuxiu Training Center (启真毓秀培训中心) Training and education platform established by the institute to integrate innovation and entrepreneurship resources, offering programs in technology policy, business incubation, tech finance, IP protection, corporate management, marketing, and finance for local governments, enterprises, and entrepreneurs.
• Zhejiang Qizhen Yushan Technology Co., Ltd. (浙江启真毓善科技有限公司) Wholly-owned food science and bioengineering technology transfer platform established with Zhejiang University's College of Biosystems Engineering and Food Science. Integrates food, biology, chemical engineering, nutrition, computer science, and mechanical engineering to focus on future food technology incubation and investment.
• Zhejiang Qizhen Medical Health Technology Co., Ltd. (浙江启真医健科技有限公司) Wholly-owned medical health technology transfer platform established with Zhejiang University Health Industry Innovation Research Center. Focuses on incubating medical-engineering transformation projects from Zhejiang University affiliated hospitals.
• Multi-Fund Venture Capital Management Services Fund management and investment services spanning multiple venture capital and parent funds including ZJU Parent Fund (500M RMB), Zhehua Zijing Parent Fund (3B RMB), Suzhou Jinshajiang Phase II Fund (1-1.5B RMB), ZJU Lianchuang Phase I Fund (100M RMB), Hangzhou Silicon Valley 2.0 Fund, Haibang Biomedical Fund (300M RMB), Jiaxing Youchuang Qizhen Fund (91M RMB), and others covering IT, semiconductors, life and health, new energy, environmental protection, and advanced manufacturing.

Quantifiable outcome

• The institute has incubated/ invested in multiple companies that achieved unicorn status (同盾科技, 邦盛科技), successful IPOs (英派药业 HKEX, 普昂医疗 BJSE, 天元宠物 SZSE, 连连数字 HKEX, 云知声 HKEX, 斯瑞新材 STAR Market), and numerous 准独角兽 recognitions.
• +2 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eleven partnerships are on record, tiered minor.

• 杭州市西湖区古墩路83号浙商财富中心minorOthersThe institute rents office space at the Zheshang Fortune Center, which also hosts other technology companies and financial institutions, creating a local ecosystem.
• 杭州城西科创大走廊minorStrategic or Co-development PartnerThe institute collaborates with Hangzhou West Coast Innovation Corridor (a major technology innovation zone) on talent programs, joint investments, and ecosystem building activities.
• 安邦护卫科技服务有限公司 (Anbang Technology)minorStrategic or Co-development PartnerThe institute collaborated with 安邦科技 on robotics ecosystem co-building. 安邦科技 signed a cooperation agreement at the opening ceremony of the Hangzhou Robot School, co-built with Hangzhou West Coast Science & Technology Innovation Corridor and Zhejiang University Robot Research Institute.
• 江门市人力资源和社会保障局minorStrategic or Co-development PartnerThe institute co-organized the 江门市乐业江门 创业创新领航培训班 with the Jiangmen Municipal Human Resources and Social Security Bureau, providing entrepreneurship training with ¥10,000 government subsidy per participant.
• 浙江邦盛科技有限公司 (Zhejiang Bangsheng Technology)minorOthersPortfolio company — a financial real-time fraud detection technology provider. The institute invested in the company, which has become a unicorn with products including 金融实时交易反欺诈, 申请反欺诈, and 信贷风控 solutions serving 400+ large customers.
• 浙大创新院工会小组minorOthersThe institute's internal labor union organizes cultural activities (e.g., 坚定文化自信，激发奋进力量) and collective outings (四明山 spring trip) to build team cohesion.
• 浙大一院临床药学部党支部minorStrategic or Co-development PartnerThe institute's party branch collaborated with the Clinical Pharmacy Department of the First Affiliated Hospital of Zhejiang University School of Medicine for a joint party-building event, including first aid training and knowledge sharing.
• 浙大长三角智慧绿洲创新中心 (未来食品实验室)minorStrategic or Co-development PartnerThe institute collaborates with Zhejiang University Yangtze River Delta Smart Oasis Innovation Center's Future Food Lab on food technology research and commercialization. The lab is researching cell-cultured fish protein as a sustainable food source. Multiple projects from this collaboration are in the industrialization stage.
• 浙江省科技信息研究院 (Zhejiang Institute of Science and Technology Information)minorStrategic or Co-development PartnerThe institute's party branch entered into a 双融共促 (dual integration) agreement with the third party branch of the Zhejiang Institute of Science and Technology Information, focusing on party-building and business collaboration.
• 浙大创新院参投企业 (Portfolio Companies Ecosystem)minorOthersPortfolio companies including 飞步科技, 英派药业, 邦盛科技, 普昂医疗, 天元宠物, 连连数字, 云知声, 斯瑞新材 etc. form an ecosystem that generates investment returns, creates deal flow synergies, and enhances the institute's reputation as a technology investment platform.
• 浙江浙商财富中心minorOthersThe institute's headquarters is located at Zheshang Fortune Center (浙商财富中心), which also hosts the Zhejiang University Innovation Technology Research Institute. The center is managed and partly owned by the institute, which has also rented out office space there (4.7-4.3 RMB/sqm/day for 735 sqm at 9F).

Scale indicators3 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• CAS Star (中科创星): A leading Chinese Academy of Sciences (CAS)-affiliated venture capital firm dedicated to commercializing hard-tech and frontier science research. Directly comparable model of academic research translation into investable startups.
• Tsinghua Holdings (清华控股): Tsinghua University's principal investment and tech-transfer platform; operates the largest university-affiliated investment portfolio in China across life sciences, advanced manufacturing, and ICT. Same business model: university IP commercialization, fund management, and ecosystem incubation.
• Shanghai Jiao Tong University Science Park (上海交通大学科技园): SJTU's dedicated technology transfer and incubation arm; runs university research parks and seed/venture funds translating SJTU IP into commercial ventures. Mirrors ZJU Innovation Institute's structure and mandate.
• Zijing Valley Innovation and Entrepreneurship Development Center (紫荆谷创新创业发展中心): A Tsinghua-linked cross-border innovation platform with a similar focus on technology transfer, training programs, and entrepreneur development. Comparable business mix of training events, competitions, and university-driven incubation.
• Peking University Science Park (北大科技园): Peking University's tech-transfer, incubation, and investment platform. Operates university-affiliated science parks, incubators, and investment funds focused on PKU research commercialization.

Broad incumbents

• Tsinghua Tongfang (同方股份): The publicly listed arm of Tsinghua Holdings; operates commercial businesses across computing, digital TV, smart transportation, and energy. Comparable as a university-affiliated commercialization vehicle but at much larger scale and listed-status maturity.
• Shenzhen Capital (深创投): A large state-backed VC/PE firm with extensive presence across Chinese technology and life-sciences investments. Provides benchmark for AUM scale and governmental partnership models relevant to the institute's structure.
• Sinovation Ventures (创新工场): A leading Chinese tech VC founded by former Google China head; invests in AI, robotics, and digital health. Overlapping investment focus (especially AI and autonomous systems) makes it a comparable capital allocator.
• SoftBank China Capital (软银中国资本): China-focused venture and growth capital arm of SoftBank; invests broadly in technology and growth-stage companies across China with parallel late-stage and growth-equity exposure comparable to the institute's later-stage funds.
• Qiming Venture Partners (启明创投): One of China's leading technology-focused venture capital firms; invests across healthcare, IT, and consumer tech. Overlaps with the institute's investment themes and serves as a co-investor in multiple funds and portfolio companies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/%E6%B5%99%E6%B1%9F%E5%A4%A7%E5%AD%A6%E5%88%9B%E6%96%B0%E6%8A%80%E6%9C%AF%E7%A0%94%E7%A9%B6%E9%99%A2%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 浙江大学创新技术研究院有限公司